Diseases that Harm Require Therapies that Harm Less

---Sir William Osler(1849-1919)
Home > News > Newsletter
ISMIVS Newsletter January&February, 2022
Newsletter 2022 January & February
2022年1&2月简报
About Us 国际微无创医学会简介
The International Society of Minimally Invasive and Virtual Surgery (ISMIVS, previously known as International Society of Minimally Invasive and Noninvasive Medicine) was founded in July 2013 at the gala of the 1st Yangtze International Summit of Minimally Invasive and Noninvasive Medicine in Chongqing, China. ISMIVS envisions to accelerating the progress in minimally invasive and noninvasive medicine by promoting research, education, communication, and international collaboration.
国际微无创医学会(ISMIVS)是在 2013 年 7 月在中国重庆召开的第一届国际微无创医学长江高峰论坛上宣布成立的,旨在通过学术研究、教育、交流以及国际合作加快微无创医学的发展。
Become a member 注册成为会员 >
The Personality in the Medical Education World 医学教育界的大人物
Professor Amphan Chalermchockcharoenkit
M.D. Faculty of Medicine, Siriraj Hospital Mahidol University
Amphan Chalermchockcharoenkit教授
泰国玛希隆大学诗里拉格(Siriraj)医院医学博士

President of Thai Society of Gynecologic Endoscopists
Director of Thai-German Multidisciplinary Endoscopic Training Center
Head of Gynecologic Endoscopy Unit Department of Obstetrics and Gynecology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok Thailand
泰国妇科内镜学会(TSGE)主席
泰德多学科内镜培训中心(TG-MET)主任
泰国玛希隆大学诗里拉格(Siriraj)医院妇产科内镜科室主任

Professor Amphan Chalermchockcharoenkit is an Associated Professor in Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital Mahidol University. Obtaining a two-year grant, he trained in Gynecologic Endoscopy at the Department of Obstetrics and Gynecology, Rosenhoehe-Bielefeld Hospital, Germany. From 2007 onwards, he has been the director of the Thai-German Multidisciplinary Endoscopic training center (TG-MET center) in Thailand. Since 2015 he is the president of the Thai Society of Gynecologic Endoscopists (TSGE). He is actively involved in many societies. These include a board member of the Asia-Pacific Association for Gynecologic Endoscopy and Minimal Invasive Surgery (APAGE), the Asia-Pacific Gynecological Endoscopy Training Group (APGET) and the Asian Society of Endometriosis and Adenomyosis (ASEA).
Amphan Chalermchockcharoenkit 教授是泰国玛希隆大学诗里拉格(Siriraj)医院妇产科的副教授。他曾获得两年的奖学金,在德国 Rosenhoehe-Bielefeld 医院接受妇科内窥镜的培训。自 2007 年起,他一直担任泰德多学科内镜培训中心(TG-MET)的主任。自 2015 年以来,他是泰国妇科内镜学会(TSGE)的主席。他也是多个学会的常务理事,包括亚太妇科内镜及微创治疗医学会(APAGE),亚太妇科内镜培训组(APGET)和亚洲子宫内膜异位症及子宫腺肌症协会(ASEA)。
As a course director, he has arranged more than 20 international cadaveric workshops. He developed many MIGS innovative instruments such as a laparoscopic training model, trocars, vaginal tubes, and morcellation bags. Many innovative MIGS procedures such as en bloc in deep endometriosis excision for radical and conservative laparoscopic surgeries, sophisticated vaginal vault closure, octopus tentacle morcellation and multi-division morcellation techniques were also developed by him. Being an expert in his field, he has been an invited speaker and chair to numerous domestic and international scientific conferences where he spoke in a variation of topics from basic to advance endoscopic surgery such as en bloc in deep endometriosis excision for radical and conservative laparoscopic surgeries, and laparoscopic gynecologic oncology.
作为医学课程导师,他发起了 20 余个研究尸体标本的国际研讨会。他开发了许多用于妇科微创手术(MIGS)的创新器具,比如腹腔镜培训模型、套管针、阴道管和分碎袋。同时开发了许多 MIGS 创新技术,比如用于根治性和保守性腹腔镜手术的深部子宫内膜异位症全切术,先进阴道穹窿闭合术、章鱼触手切除术和多部位切除术。作为妇科微创领域的专家,他受邀作为演讲嘉宾和主席,参与了许多的泰国和国际学术会议,发表了不同主题的演讲——从基础到先进的内窥镜手术(如根治性和保守性腹腔镜手术的深部子宫内膜异位症全切术),以及腹腔镜妇科肿瘤学。
Prof. Amphan has a number of publications in peer-reviewed national and international journals. He has written many chapters of book-related endometriosis and minimally invasive gynecologic surgery.
Amphan 教授在泰国和国际的同行评议期刊上发表过多篇文章,也曾为子宫内膜异位症和微无创妇科手术的有关书籍撰写过许多章节。
Read his article in laparoscopic hysterectomy:
阅读他发表的有关腹腔镜子宫切除术的文章:
https://pubmed.ncbi.nlm.nih.gov/25916961/
Watch his surgery video for severe endometriosis:
观看他治疗严重子宫内膜异位症的手术视频:
https://youtu.be/T-hsn2nTnco

Case Studies 病例分享
While there are clear limitations to the methodology of case studies in the determination of treatment protocol and establishment of new trials, the observation of a single patient can add to our understanding of aetiology, pathogenesis, natural history, treatment option and complications to promote the medical development of a particular disease, and to the clinical practice of potential junior investigators.
尽管病例研究方法在确定治疗方案、组织新的临床试验方面存在明显局限性,但对单个病例的观察研究可以帮助我们了解病因、发病机制、自然病程、治疗方法及并发症,从而促进特定疾病的医学发展,并助益初级研究人员的临床实践。
The case below was shared by Prof. Chyi-Long Lee, the Chairman of the Aisa-Pacific Association of GYN Endoscopists & Minimally Invasive Therapy (APAGE), on APAGE-ISMIVS HIFU Series Webinar: Episode 4.
本期病例由亚太妇科内镜及微创治疗医学会(APAGE)主席李奇龙教授在2021年APAGE与ISMIVS联合会议暨第4期高强度聚焦超声系列线上研讨会上分享。
Patient Info 病人情况
-37 y/o female
-G0P0
-Primary infertility for 5 years
-37岁女性
-G0P0
-患原发性不孕症5年/td>
Treatment Timeline 治疗时间线
2020.06

Dysmenorrhea
MRI: adenomyosis 5.4cm at posterior low corpus
CA-125:19.1, LDH: 252
s/p GnRH-a for a month at LMD
痛经
MRI发现后低位子宫腺肌症5.4cm
CA-125:19.1, LDH: 252
接受GnRH-a治疗一个月

2020.08
HIFU obtained 96%NPA
Contraception with advice for 6 months
接受HIFU治疗,术后非灌注区域96%
2021.04
Pregnancy via IVF
通过IVF成功妊娠
2021.12
EDC
预产期12月

Watch the whole lecture >
Notice通知
IWD-HIFU 2022:Empowering Women to Improve Health
The 1st Announcement
第三届全球多中心远程协同手术活动通知
科技赋能,关爱女性
Hundreds of millions of women globally are suffering from gynaecological disorders which may cause serious physical and psychological problems and significantly reduce their quality of life and productivity. International Women’s Day (IWD) is a global day celebrating the social, economic, cultural, and political achievements of women. The day also marks a call to action for improving and protecting women’s health and well-being.
全球数以亿计的妇女饱受妇科疾病的困扰,这些疾病可能会对她们造成严重的生理和心理问题,并大大降低了她们的生活质量和工作效率。国际妇女节是庆祝妇女所取得的社会、经济、文化及政治成就的全球性节日,也是呼吁改善、保护妇女健康和福祉的重要纪念日。
To put the idea of a global philanthropic event for women’s health from Dr Lee Keen Whye into practice, the International Society of Minimally Invasive and Virtual Surgery (ISMIVS) and the National Engineering Research Center of Ultrasound Medicine of China (NERCUM) have co-initiated and organized a multi-center High Intensity Focused Ultrasound (HIFU) treatment event since 2020 to highlight issues related to uterine fibroids, adenomyosis and other gynaecological diseases and raise awareness of gynaecological examination and treatment.
以此为背景,新加坡的李健威医生提出了举办关爱妇女健康的全球大型公益活动的构思,而后得到了国际微无创医学会(ISMIVS)和中国超声医疗工程研究中心(NERCUM)的积极响应,于 2020 年共同发起并举办了首届多中心高强度聚焦超声(HIFU)治疗活动。该活动是一场围绕子宫肌瘤、子宫腺肌症等妇科疾病的全球公益活动,旨在提高女性进行妇科检查和治疗的意识。
Themed on Empowering Women to Improve Health, IWD-HIFU 2022 will not only pass the spirit of the last two terms of IWD-HIFU but also be ready to take further steps to influence more women around the world. As one of its pioneering actions, IWD-HIFU 2022 is about to broadcast the world’s first trans-provincial live HIFU surgery. Moreover, for the first time, IWD-HIFU 2022 will appraise and elect HIFU clinicians for the honour of the Annual HIFU Influencers of 2021 to mark their great efforts in improving women’s health consciousness through vigorous online/offline activities.
第三届全球多中心远程协同手术活动(2022 年 3 月 7 日)以“科技赋能,关爱女性”为主题,不仅延续了过去两届活动的公益精神,还在此基础上丰富了活动内容,希望能够影响世界各地更多的妇女。本届活动将开创性地开展世界首台跨省聚焦超声消融远程手术,并首次开办“年度HIFU科普达人”评选颁奖仪式,以表彰 HIFU 医务人员为提高女性健康意识通过线上或线下活动而付出的巨大努力。
We are now inviting all the international HIFU Centers to participate IWD-HIFU 2022 and provide noninvasive uterus-sparing HIFU treatment for patients with uterine fibroids and/or adenomyosis, which will be broadcast live by NERCUM and witnessed by news media. To celebrate International Women’s Day, we sincerely call every HIFU center to sign up for this major philanthropic event for providing patients with a public-spirited HIFU therapy at a preferential price.
在此,我们邀请世界各地的 HIFU 中心参与本届全球多中心远程协同手术公益活动,为子宫肌瘤和/或子宫腺肌症患者提供以无创、保子宫为治疗目标的 HIFU 治疗。本届活动将通过 NERCUM 现场直播,并由各大媒体采访报道。为纪念国际三八妇女节这一特殊的日子,我们真诚地呼吁参与本届活动的所有 HIFU 中心,免除当天参与直播的患者的部分治疗费用,贯彻公益精神,传播大爱。
Date: 14:00 – 17:00 (UTC/GMT+8), March 7th (Monday), 2022
How to participate: Please contact Ms Hannah Xu (hannahxu@isminim.org)
活动日期:2022年3月7日(周一)14:00 至 17:00(北京时间)
报名方式:请联系ISMIVS秘书处 (hannahxu@isminim.org) 报名

For More Details About IWD-HIFU 2022 >

HIFU Special Issue 高强度聚焦超声特刊
We are delighted to announce that International Journal of Hyperthermia, the HIFU Special Issue (i.e. Volume 38, 2021), which was partially supported by ISMIVS, was officially released on September. The Special Issue includes 15 articles written and reviewed by world-renowned scholars and pioneers in the minimally invasive and noninvasive medicine, elaborating the status and prospects of the clinical applications of high intensity focused ultrasound on tumors occurred in certain organs. We'll share the 15 articles included in the upcoming newsletters, stay tuned!
我们很高兴地向大家宣布,由国际微无创医学会(ISMIVS)参与并大力支持的《国际热疗杂志:高强度聚焦超声(HIFU)特刊》已于九月正式发布。本期特刊邀请到多位微无创医学领域的国际知名专家和行业先驱参与编撰及审核,共包含15篇学术文章,阐述了高强度聚焦超声(HIFU)治疗人体各器官肿瘤的临床应用现状和发展前景。我们将陆续分享HIFU特刊中的文章,敬请期待!
Efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for uterine fibroids: an observational single-center study
超声引导下高强度聚焦超声(USgHIFU)保守治疗子宫肌瘤的疗效:一项单中心观察性研究
This article is to evaluate the treatment response of uterine fibroids after ultrasound-guided high-intensity focused ultrasound (USgHIFU) with a special focus on fibroid size and characterization based on the Funaki classification scheme, as well as clinical response to treatment of leading fibroid-associated symptoms.
本研究评估超声引导高强度聚焦超声 ( USgHIFU )治疗子宫肌瘤后的治疗反应,特别关注基于 Funaki 分类方案的肌瘤大小和特征,以及对主要肌瘤相关症状治疗的临床作用。
Uterine fibroids treated by USgHIFU were assigned to Funaki type 1–3 based on T2-w-MRI. Differences in size, non-perfused volume ratio (NPVR) and volume reduction over time were determined using T1-/T2-w MRI sequences and contrast-enhanced sonography.
根据 T2-w-MRI,USgHIFU 治疗的子宫肌瘤属于 Funaki 1-3 型。 使用 T1-/T2-w MRI 序列和对比增强超声检查确定肌瘤大小、非灌注体积比( NPVR )的变化,以及随时间减少的肌瘤体积。
Following USgHIFU, significant shrinkage of uterine fibroids and improvement of leading fibroid-associated symptoms were demonstrated regardless of the Funaki type.
接受 USgHIFU 之后,无论属于哪种 Funaki 类型,均显示子宫肌瘤的显著缩小和主要病症的改善。
Read More >
Tech Update in Gynaecological Endoscopy 妇科腔镜技术最新进展
Peri-operative and survival outcomes analysis of patients with endometrial cancer managed by three surgical approaches: a long-term Bulgarian experience
三种手术方式下子宫内膜癌患者的围手术期和生存结果分析:保加利亚的一次长期经验
The aim of this study was to retrospectively assess the perioperative, oncologic, and survival outcomes for patients with endometrial cancer (EC) managed by abdominal hysterectomy (AH), laparoscopic hysterectomy (LH), or robotic hysterectomy (RH) approaches at premier centers in Bulgaria. Consecutive 917 patients (AH=466; LH=60, RH=391) formed the basis of study analyses.
本研究的目的是回顾性评估在保加利亚一流的临床中心采用剖腹式子宫切除术 ( AH )、腹腔镜子宫切除术 ( LH ) 或机器人子宫切除术 ( RH ) 治疗子宫内膜癌 ( EC ) 患者的围手术期、肿瘤学和生存结果。 本次研究分析的对象为连续治疗的 917 名患者(AH=466;LH=60,RH=391)。
Their>10-years experience demonstrated better outcomes for the MIS compared to open surgery in terms of postoperative haemoglobin, blood transfusions, and LOS, with no difference in the complications rate.
超过10 年的经验表明,在术后血红蛋白、输血和 LOS 方面,微创手术( MIS ) 的结果优于开腹手术,并发症发生率没有差异。
They also observed that compared to laparoscopic and laparotomy surgery, robotic-assisted surgery allows for easier treatment of patients with EC due to overcoming the barriers of the other two types of hysterectomy procedures.
他们还观察到,与腹腔镜和剖腹手术相比,机器人辅助手术克服了其他两种子宫切除术的障碍,更易于治疗EC患者。
Read More >
isminim@isminim.org ISMIVS
+86 23 67886199 ISMIVS
www.isminim.com ISMIVS
No.359, Jingdongfang Avenue, Beibei District, Chongqing, P.R.China

ISMIVS

ISMIVS

+86 23 67886199

ISMIVS 2020